L-asparaginase--clinical experience in leukaemia, lymphoma and carcinoma.
D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D002986:Clinical Trials as Topic; D005164:Factor IX / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D010958:Plasminogen / Q000032:analysis
D005164:Factor IX; D005340:Fibrinogen; D010958:Plasminogen; D001215:Asparaginase